Media Pack
News

Current Edition

Volume 7 issue 1

Upcoming Events

 
 

Advertisement

 
news

In final analysis, Pfizer’s COVID-19 pill remains highly effective

Final study results show Pfizer's experimental COVID-19 pill remained as effective as indicated by preliminary data last month, a major relief after promising data fo...
15 December 2021 news COVID-19 pill | data
Continue Reading →
news

New Merck study results raise questions about its COVID pill

Final trial data for molnupiravir were less convincing than what Merck previously reported and could alter how the FDA views the drug. New study results disclosed by...
3 December 2021 news COVID-19 pill | Food and Drug Administration
Continue Reading →
news

Pfizer will allow generic drugmakers to produce promising COVID-19 pill

Pfizer is sharing rights to make its COVID-19 pill even as it closely guards the recipe for its coronavirus vaccine, which has mostly been supplied to high- or upper ...
19 November 2021 news COVID-19 pill | generic drugmakers
Continue Reading →
news

Pfizer asks FDA to authorize COVID-19 pill

Pfizer's pill is the second oral drug for COVID-19 to be proven strongly effective in large, placebo-controlled clinical trials after Merck's molnupiravir, which earl...
19 November 2021 news clinical trials | COVID-19 pill
Continue Reading →
news

Roche cuts ties with Atea after COVID-19 pill’s trial failure

Roche's seeming lack of confidence in the future of AT-527 appears to be weighing on investors. Atea shares, which soared above $88 in February 2021, dropped 20% to b...
19 November 2021 news Atea | clinical trial
Continue Reading →
news

US pays $1B to nearly double supply of Merck’s COVID-19 pill

Merck is now in a race with Pfizer to capture the upside of COVID-19 pills, which could soon play an outsized role in the next phase of the pandemic and beyond. The ...
15 November 2021 news COVID-19 pill | Merck
Continue Reading →
news

Merck agrees to license COVID-19 pill widely through pact with patent group

Merck's pill has the potential to alter the course of the pandemic. Earlier this month, the company and partner Ridgeback Biotherapeutics released data showing molnup...
29 October 2021 news COVID-19 | COVID-19 pill
Continue Reading →
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte